Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Recent research suggests that vitamin supplements may increase the risk of developing cancer.

2.

An FDA panel supports the use of CAR T-cell therapy earlier in the treatment of multiple myeloma.

3.

In-person and Virtual Palliative Care Are Both Beneficial for Advanced Lung Cancer Patients.

4.

How cancer misinformation exploits the way we think

5.

Making informed decisions and managing regret after prostate cancer treatment


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot